NSEUpdates23h ago · 30 Oct 2026, 04:59 pm

Updates

Paras Healthcare Limited · PARASHLTH

✦ AI SummaryPledge

Paras Healthcare Limited has informed the Exchange regarding 'Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended ( SEBI SAST Regulations )'. The company has received a disclosure from 360 ONE Special Opportunities Fund – Series 9 to 13 and 360 ONE Private Equity Fund- Series 2 and 360 ONE Equity Opportunity Fund- Series 4 regarding their acquisition of shares in the company.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Paras Healthcare Limited has informed the Exchange regarding 'Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended ( SEBI SAST Regulations )'.

Attachments (1)

📄

PARASHEALTH_30102026165908_Disclosure_-_Regulation_29_1__-_SAST_-_Final.pdf

pdf

Download →
View document text
Date: October 30, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (E), Mumbai – 400051 BSE Scrip Code: 545005 NSE Scrip Symbol: PARASHLTH Subject: Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended (“SEBI SAST Regulations”) Dear Sir/Madam, Please find enclosed the disclosure received by the Company today, i.e., October 30, 2026, being the Target Company under the SEBI SAST Regulations, from the below persons, being the Acquirer under the SEBI SAST Regulations, along with the persons acting in concert (“PAC”) with it, pursuant to Regulation 29(1) of the SEBI SAST Regulations. Name(s) of the acquirer and Persons Acting in Concert (“PAC”) with the acquirer 360 ONE Special Opportunities Fund – Series 9 360 ONE Special Opportunities Fund – Series 10 360 ONE Special Opportunities Fund – Series 11 360 ONE Special Opportunities Fund – Series 12 360 ONE Special Opportunities Fund – Series 13 360 ONE Private Equity Fund- Series 2 360 ONE Equity Opportunity Fund- Series 4 This disclosure will also be hosted on the Company’s website at https://www.parashospitals.com/investors. You are requested to take the same on your record. Thanking you. For Paras Healthcare Limited Rahul Kumar Company Secretary and Compliance Officer ICSI Membership No.: A20928 Encl.: As above Format for Disclosures under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Part A- Details of the Acquisition Name of the Target Company (TC) PARAS HEALTHCARE LIMITED Name(s) of the acquirer and Persons Acting in Scheme Concert (PAC) with the acquirer 360 ONE Special Opportunities Fund Series 9 360 ONE Special Opportunities Fund- Series 10 360 ONE Special Opportunities Fund- Series 11 360 ONE Special Opportunities Fund- Series 12 360 ONE Special Opportunities Fund- Series 13 360 ONE Private Equity Fund- Series 2 360 ONE Equity Opportunity Fund- Series 4 Whether the acquirer belongs to No Promoter/Promoter group Name(s) of the Stock Exchange(s) where the BSE Limited NSE Limited shares of TC are Listed Details of acquisition as follows Number % w.r.t. total % w.r.t. share/ voting total diluted capital share/ voting wherever capital of applicable (*) the TC (**) Before the acquisition under consideration, 78,81,992 7.28% 7.28% holding of acquirer along with PACs of: a) Shares carrying voting rights b) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) c) Voting rights (VR) otherwise than by equity shares d) Warrants/ convertible securities/ any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) Details of acquisition Nil NA NA a) Shares carrying voting rights acquired b) VRs acquired otherwise than by equity shares c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired. d) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) e) Total (a+b+c+/-d) After acquisition, holding of acquirer along 78,81,992 7.28% 7.28% with PACs of: a) Shares carrying voting rights b) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) Shares pledged with the acquirer. c) VRs otherwise than by equity shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after disposal e) Total (a+b+c+d) Mode of acquisition (e.g. open market/ public Unlisted shares conversion into listed shares on account issue/ rights issue/ preferential allotment/ of an IPO inter-se transfer, etc.) Date of acquisition of shares VR/ warrants/ October 28, 2026 (listing date) convertible securities/ any other instrument that entitles the acquirer to receive shares in the TC. Equity share capital/ total voting capital of 10,82,01,194 Shares as per shareholder pattern as on October 27, 2026 disclosed on BSE. the TC before the said acquisition Equity share capital/ total voting capital of 10,82,01,194 Shares as per shareholder pattern as on October 27, 2026 disclosed on BSE. the TC after the said acquisition Total diluted share/ voting capital of the TC 10,85,00,790 Shares as per shareholder pattern as on October 27, 2026 disclosed on BSE. after the said acquisition For 360 ONE Alternates Asset Management Limited For 360 ONE Asset Management Limited (Investment Manager) (Investment Manager) Vijay Shah Sonali Tendulkar Compliance Officer Compliance Officer Place: Mumbai Date: October 30, 2026 Note: (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement for the listing date October 28, 2026. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.